White Paper
The Driving Force Of Technology
Click Here To Download:
•Article: The Driving Force Of Technology
Michael McGrath and Tom O'Leary of ICON investigate how the use of technology is evolving within clinical trials with ideas fueled by an industry roundtable discussion.
A recent industry roundtable, hosted by ICON, reinforced the general industry view that the use of technology is one of the backbones of clinical research studies. Participants not only agreed that technology is becoming widely adopted in clinical trials, but that there are some very clear and distinct drivers fueling this adoption.
One such factor is the drive in efficiency in the drug development process, which is improving the quality and speed of data collection, thereby achieving shorter time to market and lowering costs. In addition, because the pharmaceutical industry is international and organisations are multi-site and multi-country with truly global virtual teams, technology already plays a pivotal role in facilitating and speeding up both internal and external communication. Technology helps pharmaceutical companies share information faster and more efficiently, thereby generating higher quality data in a shorter timeframe while at the same time lowering development costs.
This article written by Michael McGrath and Tom O'Leary of ICON first appeared in International Clinical Trial, pp. 36-38, Summer issue 2007, www.samedanltd.com/magazine/13. Reprinted with permission.
Click Here To Download:•Article: The Driving Force Of Technology
